Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Gonane Triamcinolone

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Vamsi Lab Triamcinolone

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Triamcinolone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,694Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of January 14, 2026
    Enforcement Report - Week of January 14, 2026

    14 Jan 2026

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-14-2026-32682.pdf

    FDA
    14 Jan 2026
    Share Share
    Coral Drugs Receives CEP Approval for Triamcinolone!
    Coral Drugs Receives CEP Approval for Triamcinolone!

    31 Jul 2025

    // PRESS RELEASE

    https://www.coraldrugs.com/news/coral-drugs-receives-cep-approval-for-triamcinolone

    PRESS RELEASE
    31 Jul 2025
    Share Share
    Clearside’s XIPERE® Approved in Canada for Macular Edema
    Clearside’s XIPERE® Approved in Canada for Macular Edema

    23 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/23/3120111/0/en/Clearside-Biomedical-Announces-Approval-of-XIPERE-Suprachoroidal-Treatment-for-Uveitic-Macular-Edema-in-Canada.html

    GLOBENEWSWIRE
    23 Jul 2025
    Share Share
    Pacira Bio Reports Inducement Grants Under Nasdaq LR 5635(C)(4)
    Pacira Bio Reports Inducement Grants Under Nasdaq LR 5635(C)(4)

    07 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/07/2958873/0/en/Pacira-BioSciences-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-C-4.html

    GLOBENEWSWIRE
    07 Oct 2024
    Share Share
    Pacira BioSciences Reports Inducement Grants Under Nasdaq
    Pacira BioSciences Reports Inducement Grants Under Nasdaq

    09 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/09/2943191/0/en/Pacira-BioSciences-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-C-4.html

    GLOBENEWSWIRE
    09 Sep 2024
    Share Share
    Clearside's Partner Reports Positive Phase 3 Results For ARCATUS In China
    Clearside's Partner Reports Positive Phase 3 Results For ARCATUS In China

    29 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/29/2920608/0/en/Clearside-Biomedical-s-Partner-Arctic-Vision-Reports-Positive-Topline-Results-from-Phase-3-Clinical-Trial-of-ARCATUS-for-Suprachoroidal-Use-in-Uveitic-Macular-Edema-Patients-in-Chi.html

    GLOBENEWSWIRE
    29 Jul 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.